Abstract
Respiratory syncytial virus (RSV) accounts for considerable morbidity among infants and elderly, that are otherwise immunocompetent. Immunocompromised haematological patients - in particular bone marrow transplant (BMT) recipients with leukopenia - are at high risk for severe, usually fatal, RSV-pneumonia. No randomized, placebo-controlled studies of aerosolized ribavirin for BMT patients with RSV-pneumonia have been conducted, or can be anticipated. We summarize existing case reports providing circumstantial evidence in favour of an active diagnostic and early therapeutic approach to these patients.
Bidragets oversatte titel | Treatment of respiratory syncytial viral infections in immunocompromised haematological patients |
---|---|
Originalsprog | Dansk |
Tidsskrift | Ugeskrift for Laeger |
Vol/bind | 162 |
Udgave nummer | 35 |
Sider (fra-til) | 4644-4647 |
Antal sider | 4 |
ISSN | 0041-5782 |
Status | Udgivet - 28 aug. 2000 |
Udgivet eksternt | Ja |